Ryanodine Receptor Phosphorylation, Calcium/Calmodulin-Dependent Protein Kinase II, and Life-Threatening Ventricular Arrhythmias

Trends in Cardiovascular Medicine

Volumn 21, Issue 2, 2011, Pages 48-51

  McCauley, Mark D ^a   Wehrens, Xander H T ^b  

^a BAYLOR COLLEGE OF MEDICINE   (United States)

^b TEXAS HEART INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CALCIUM CALMODULIN DEPENDENT PROTEIN KINASE II; RYANODINE RECEPTOR 2;

CALCIUM TRANSPORT; CARDIOMYOPATHY; CARDIOVASCULAR RISK; GENE MUTATION; GENETIC PREDISPOSITION; HEART DEATH; HEART VENTRICLE ARRHYTHMIA; HISTOPATHOLOGY; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN PHOSPHORYLATION; REVIEW; SIGNAL TRANSDUCTION;

ARRHYTHMIAS, CARDIAC; CALCIUM-CALMODULIN-DEPENDENT PROTEIN KINASE TYPE 2; HUMANS; PHOSPHORYLATION; RYANODINE RECEPTOR CALCIUM RELEASE CHANNEL;

EID: 84860823877     PISSN: 10501738     EISSN: 18732615     Source Type: Journal    
DOI: 10.1016/j.tcm.2012.02.004     Document Type: Review

References (42)

1. 2+ leak in heart failure. Circ Res 2005, 97:1314-1322.
2. 2+ channel erupts and dribbles. Circ Res 2005, 97:1213-1215.
3. Anderson M.E., Brown J.H., Bers D.M. CaMKII in myocardial hypertrophy and heart failure. J Mol Cell Cardiol 2011, 51:468-473.
4. Bell J.R., Curl C.L., Ip W.T., et al. Ca(2+)/calmodulin-dependent protein kinase inhibition suppresses post-ischemic arrhythmogenesis and mediates sinus bradycardic recovery in reperfusion. Int J Cardiol [Epub ahead of print] 2011.
5. Bers D.M. Cardiac excitation-contraction coupling. Nature 2002, 415:198-205.
6. Bers D.M. Ca(2)-calmodulin-dependent protein kinase II regulation of cardiac excitation-transcription coupling. Heart Rhythm 2011, 8:1101-1104.
7. Bers D.M., Guo T. Calcium signaling in cardiac ventricular myocytes. Ann N Y Acad Sci 2005, 1047:86-98.
8. Cerrone M., Colombi B., Santoro M., et al. Bidirectional ventricular tachycardia and fibrillation elicited in a knock-in mouse model carrier of a mutation in the cardiac ryanodine receptor. Circ Res 2005, 96:e77-e82.
9. Cerrone M., Noujaim S.F., Tolkacheva E.G., et al. Arrhythmogenic mechanisms in a mouse model of catecholaminergic polymorphic ventricular tachycardia. Circ Res 2007, 101:1039-1048.
10. 2+ leak promotes atrial fibrillation in mice. J Clin Invest 2009, 119:1940-1951.
11. Currie S. Cardiac ryanodine receptor phosphorylation by CaM Kinase II: Keeping the balance right. Front Biosci 2009, 14:5134-5156.
12. Erickson J.R., Joiner M.L., Guan X., et al. A dynamic pathway for calcium-independent activation of CaMKII by methionine oxidation. Cell 2008, 133:462-474.
13. 2+/calmodulin-dependent protein kinase II. Circ Arrhythm Electrophysiol 2011, 4:379-387.
14. Gyorke S. Molecular basis of catecholaminergic polymorphic ventricular tachycardia. Heart Rhythm 2009, 6:123-129.
15. He B.J., Joiner M.L., Singh M.V., et al. Oxidation of CaMKII determines the cardiotoxic effects of aldosterone. Nat Med 2011, 17:1610-1618.
16. 2+ spark mass. J Mol Cell Cardiol 2010, 48:293-301.
17. Kannankeril P.J., Mitchell B.M., Goonasekera S.A., et al. Mice with the R176Q cardiac ryanodine receptor mutation exhibit catecholamine-induced ventricular tachycardia and cardiomyopathy. Proc Natl Acad Sci USA 2006, 103:12179-12184.
18. Khoo M.S., Li J., Singh M.V., et al. Death, cardiac dysfunction, and arrhythmias are increased by calmodulin kinase II in calcineurin cardiomyopathy. Circulation 2006, 114:1352-1359.
19. 2+/calmodulin-dependent protein kinase in failing and nonfailing human hearts. Cardiovasc Res 1999, 42:254-261.
20. Laitinen P.J., Brown K.M., Piippo K., et al. Mutations of the cardiac ryanodine receptor (RyR2) gene in familial polymorphic ventricular tachycardia. Circulation 2001, 103:485-490.
21. Lanner J.T., Georgiou D.K., Joshi A.D., et al. Ryanodine receptors: Structure, expression, molecular details, and function in calcium release. Cold Spring Harbor Perspect Biol 2010, 2:a003996.
22. Lehnart S.E., Wehrens X.H., Kushnir A., et al. Cardiac ryanodine receptor function and regulation in heart disease. Ann N Y Acad Sci 2004, 1015:144-159.
23. Li N., Wang T., Wang W., et al. Inhibition of CaMKII phosphorylation of RyR2 prevents induction of atrial fibrillation in FKBP12.6 knockout mice. Circ Res 2011, 110:465-470.
24. Little G.H., Saw A., Bai Y., et al. Critical role of nuclear calcium/calmodulin-dependent protein kinase IIdeltaB in cardiomyocyte survival in cardiomyopathy. J Biol Chem 2009, 284:24857-24868.
25. 2+ release. Circ Res 2003, 92:904-911.
26. Mathur N., Sood S., Wang S., et al. Sudden infant death syndrome in mice with an inherited mutation in RyR2. Circ Arrhythm Electrophysiol 2009, 2:677-685.
27. Netticadan T., Temsah R.M., Kawabata K., et al. Sarcoplasmic reticulum Ca(2+)/calmodulin-dependent protein kinase is altered in heart failure. Circ Res 2000, 86:596-605.
28. Priori S.G., Napolitano C., Tiso N., et al. Mutations in the cardiac ryanodine receptor gene (hRyR2) underlie catecholaminergic polymorphic ventricular tachycardia. Circulation 2001, 103:196-200.
29. Rubart M., Zipes D.P. Mechanisms of sudden cardiac death. J Clin Invest 2005, 115:2305-2315.
30. Sarma S., Li N., van Oort R.J., et al. Genetic inhibition of PKA phosphorylation of RyR2 prevents dystrophic cardiomyopathy. Proc Natl Acad Sci U S A 2010, 107:13165-13170.
31. Shan J., Betzenhauser M.J., Kushnir A., et al. Role of chronic ryanodine receptor phosphorylation in heart failure and beta-adrenergic receptor blockade in mice. J Clin Invest 2010, 120:4375-4387.
32. Swaminathan P.D., Purohit A., Soni S., et al. Oxidized CaMKII causes cardiac sinus node dysfunction in mice. J Clin Invest 2011, 121:3277-3288.
33. Toischer K., Rokita A.G., Unsold B., et al. Differential cardiac remodeling in preload versus afterload. Circulation 2010, 122:993-1003.
34. 2+-ATPase by calmodulin and protein kinase A. J Biol Chem 2005, 280:30611-30618.
35. van Oort R.J., McCauley M.D., Dixit S.S., et al. Ryanodine receptor phosphorylation by calcium/calmodulin-dependent protein kinase II promotes life-threatening ventricular arrhythmias in mice with heart failure. Circulation 2010, 122:2669-2679.
36. van Oort R.J., Respress J.L., Li N., et al. Accelerated development of pressure overload-induced cardiac hypertrophy and dysfunction in an RyR2-R176Q knockin mouse model. Hypertension 2010, 55:932-938.
37. Wagner S., Ruff H.M., Weber S.L., et al. Reactive oxygen species-activated Ca/calmodulin kinase IIdelta is required for late I(Na) augmentation leading to cellular Na and Ca overload. Circ Res 2011, 108:555-565.
38. Watanabe H., Chopra N., Laver D., et al. Flecainide prevents catecholaminergic polymorphic ventricular tachycardia in mice and humans. Nat Med 2009, 15:380-383.
39. Wehrens X.H., Lehnart S.E., Huang F., et al. FKBP12.6 deficiency and defective calcium release channel (ryanodine receptor) function linked to exercise-induced sudden cardiac death. Cell 2003, 113:829-840.
40. Wehrens X.H., Lehnart S.E., Reiken S.R., et al. Protection from cardiac arrhythmia through ryanodine receptor-stabilizing protein calstabin2. Science 2004, 304:292-296.
41. 2+/calmodulin-dependent protein kinase II phosphorylation regulates the cardiac ryanodine receptor. Circ Res 2004, 94:e61-e70.
42. 2+ release. Nat Med 2011, 17:1003-1009.